Safety information on gadodiamide issued in Canada

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1547, 2006-01, pp. : 19-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Avastin safety info issued in Canada

Reactions Weekly, Vol. 1, Iss. 1157, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Health Canada has issued both a Public Communication and a `Dear Healthcare Professional' letter advising of updated safety information for Invirase [saquinavir]

Reactions Weekly, Vol. 1, Iss. 1327, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

EU and Canada agree to exchange drug safety information

Reactions Weekly, Vol. 1, Iss. 1185, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

EU and Canada agree to exchange drug safety information

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 545, 2008-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Novartis Oncology have issued a letter alerting healthcare providers of new safety information, including a boxed warning, for Exjade

Reactions Weekly, Vol. 1, Iss. 1290, 2010-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite